Following-on from discussions held at the previous meeting on real-world evidence and the use of non-conventional data sources for pharmacovigilance purposes, the MC decided in November 2019 to proceed with the establishment of a Pharmacovigilance Working Group (PVWG) with a mandate to leverage knowledge-sharing and opportunities to advance collaboration in the area of pharmacovigilance between IPRP members. This WG will initiate activities in 2020 to develop its work plan and define steps to be taken to enhance the area of pharmacovigilance through collaborations and knowledge-sharing on appropriate methodologies to use and analyze structured and unstructured data, and to complement traditional spontaneous reporting systems through this process, when necessary.